Tyme Technologies logo
Tyme Technologies TYME

Quarterly report 2022-Q2
added 08-09-2022

report update icon

Tyme Technologies ROA Ratio 2011-2026 | TYME

Annual ROA Ratio Tyme Technologies

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-26.28 -74.58 -188.3 -61.16 -141.87 - -261.18 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-26.28 -261.18 -125.56

Quarterly ROA Ratio Tyme Technologies

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-21.92 -19.54 -36.73 -28.66 -34.03 -67.03 -77.54 -100.36 -124.9 -136.85 -148.71 -147.84 -136.15 -127.37 -121.31 -121.59 -120.5 -122.73 -149.24 -145.63 -155.3 -209.11 -242.23 -288.98 -356.95 -304.87 -313.62 -303.96 -248.18 -752.24 -1200.28 -1230.54 -716.11 -20374.94 -39483.84 -74670.06 -55020.38 -55102.36 -35525.51 -315.17 -321.32 -344.92 -286.54 -242.53 -70.79 -23.6 -23.6 -23.6

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-19.54 -74670.06 -6044.59

ROA Ratio of other stocks in the Biotechnology industry

Issuer ROA Ratio Price % 24h Market Cap Country
ADMA Biologics ADMA Biologics
ADMA
23.54 $ 16.34 -0.24 % $ 3.89 B usaUSA
MorphoSys AG MorphoSys AG
MOR
-20.13 - 2.43 % $ 254 M germanyGermany
Axsome Therapeutics Axsome Therapeutics
AXSM
-26.55 $ 165.22 0.71 % $ 8.22 B usaUSA
Graybug Vision Graybug Vision
GRAY
-217.51 - -11.23 % $ 9.65 M usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
2.08 $ 19.73 -2.13 % $ 2.49 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
-26.46 $ 0.8 1.02 % $ 4.36 M chinaChina
I-Mab I-Mab
IMAB
7.43 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
3.33 - - $ 40.3 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
-225.71 - 2.71 % $ 14 M usaUSA
Biophytis SA Biophytis SA
BPTS
-89.6 - -13.47 % $ 169 M franceFrance
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-150.49 - -11.43 % $ 502 K usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
-33.24 $ 2.85 1.25 % $ 908 M israelIsrael
AbCellera Biologics AbCellera Biologics
ABCL
-10.79 $ 3.71 -0.13 % $ 1.11 B canadaCanada
Athersys Athersys
ATHX
-144.48 - 3.77 % $ 22.4 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-53.39 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-42.28 - -18.52 % $ 27.3 M britainBritain
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
-50.64 - - $ 521 M usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
4.59 $ 59.28 1.28 % $ 11.4 B usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
-634.44 - -2.5 % $ 5.88 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
26.14 - -4.8 % $ 255 M usaUSA
Burford Capital Limited Burford Capital Limited
BUR
5.51 $ 8.56 0.12 % $ 1.38 B britainBritain
Capricor Therapeutics Capricor Therapeutics
CAPR
-37.95 $ 26.06 0.77 % $ 698 M usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
-78.3 $ 65.0 0.73 % $ 12.4 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
-72.8 - - $ 86.2 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
-24.24 - - $ 3.45 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
4.82 - - - russiaRussia
Avid Bioservices Avid Bioservices
CDMO
-41.82 - - $ 789 M usaUSA
Codexis Codexis
CDXS
-43.81 $ 1.0 2.04 % $ 73.4 M usaUSA
Certara Certara
CERT
-0.1 $ 7.43 2.56 % $ 1.19 B usaUSA
ARCA biopharma ARCA biopharma
ABIO
-21.14 - 1052.0 % $ 415 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
-752.78 - - $ 169 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
-57.1 - -16.75 % $ 25.8 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
-20.15 - - $ 2.17 B usaUSA
Clovis Oncology Clovis Oncology
CLVS
-55.94 - -7.23 % $ 13 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
-232.99 - -24.86 % $ 820 K usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
-77.89 - - $ 231 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
-37.78 $ 1.77 7.27 % $ 167 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-13.29 - 4.01 % $ 150 M canadaCanada
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
-73.85 - - $ 1.2 B usaUSA
CohBar CohBar
CWBR
-74.39 - -15.44 % $ 2.2 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
-273.86 - -5.98 % $ 34.1 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-273.86 - -4.36 % $ 27 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
-26.68 $ 3.36 3.23 % $ 3.92 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
-41.16 - - $ 2.18 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
-35.55 - - $ 867 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
-10.45 - 5.93 % $ 314 M canadaCanada
CorMedix CorMedix
CRMD
-56.47 $ 7.09 2.53 % $ 361 M usaUSA
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
-59.34 $ 17.3 -1.31 % $ 831 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
-123.72 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-19.95 - - $ 1.01 B usaUSA